Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.6M Buy
111,674
+108,540
+3,463% +$3.38M 0.01% 546
2025
Q4
$139K Buy
+3,134
New +$176K ﹤0.01% 962
2025
Q3
Sell
-133,040
Closed -$8.16M 1104
2025
Q2
$8.16M Buy
133,040
+77,215
+138% +$4.31M 0.04% 273
2025
Q1
$3.21M Buy
+55,825
New +$3.53M 0.02% 363
2024
Q1
Sell
-3,100
Closed -$86.9K 1055
2023
Q4
$86.9K Buy
+3,100
New +$73.2K ﹤0.01% 786

Other funds holding DOCS

Natixis's DOCS Position: Q1 2026 in Review

Natixis increased its Doximity (DOCS) stake by 3,463% in Q1 2026, buying an estimated $3.38M and bringing the position to 111,674 shares worth $2.6M. The position accounts for 0.01% of the portfolio, ranked #546.

Natixis first reported a position in DOCS in Q4 2023 and has held it in 5 quarters since. The position peaked at $8.16M in Q2 2025. 421 funds tracked by Wall St. Rank hold DOCS as of Q1 2026.

  • Natixis held 111,674 shares of Doximity worth $2.6M as of Q1 2026.
  • Natixis bought 108,540 Doximity shares in Q1 2026, an estimated $3.38M.
  • Doximity made up 0.01% of Natixis's portfolio in Q1 2026, its #546 holding.
  • Natixis first reported a position in Doximity in Q4 2023 and has held it in 5 quarters since.
  • Natixis's Doximity position peaked at $8.16M in Q2 2025.
  • 421 funds tracked by Wall St. Rank held Doximity as of Q1 2026.

Based on Natixis's 13F filing for Q1 2026, filed 14 May 2026.